Skip to main content
See every side of every news story
Published loading...Updated

Sweden’s Acorai bags €4.2M to advance heart failure management devices

Summary by Silicon Canals
Helsingborg-based Acorai, a Swedish company specialising in heart failure management devices, announced that it secured $4.5M (approximately €4.28M) in a fresh round of funding.  The investment, made by the European Innovation Council (EIC) Fund, Taiwan Medical University, and private investors, will support the completion of clinical studies and regulatory approvals in the US and Europe. Earlier this year, in January 2024, Acorai closed an over…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

healthcare-in-europe.com broke the news in on Monday, December 2, 2024.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal